These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 24159172)

  • 1. Desmolaris, a novel factor XIa anticoagulant from the salivary gland of the vampire bat (Desmodus rotundus) inhibits inflammation and thrombosis in vivo.
    Ma D; Mizurini DM; Assumpção TC; Li Y; Qi Y; Kotsyfakis M; Ribeiro JM; Monteiro RQ; Francischetti IM
    Blood; 2013 Dec; 122(25):4094-106. PubMed ID: 24159172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lufaxin, a novel factor Xa inhibitor from the salivary gland of the sand fly Lutzomyia longipalpis blocks protease-activated receptor 2 activation and inhibits inflammation and thrombosis in vivo.
    Collin N; Assumpção TC; Mizurini DM; Gilmore DC; Dutra-Oliveira A; Kotsyfakis M; Sá-Nunes A; Teixeira C; Ribeiro JM; Monteiro RQ; Valenzuela JG; Francischetti IM
    Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2185-98. PubMed ID: 22796577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification and partial characterization of draculin, the anticoagulant factor present in the saliva of vampire bats (Desmodus rotundus).
    Apitz-Castro R; Béguin S; Tablante A; Bartoli F; Holt JC; Hemker HC
    Thromb Haemost; 1995 Jan; 73(1):94-100. PubMed ID: 7740503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fasxiator, a novel factor XIa inhibitor from snake venom, and its site-specific mutagenesis to improve potency and selectivity.
    Chen W; Carvalho LP; Chan MY; Kini RM; Kang TS
    J Thromb Haemost; 2015 Feb; 13(2):248-61. PubMed ID: 25418421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ixolaris, a novel recombinant tissue factor pathway inhibitor (TFPI) from the salivary gland of the tick, Ixodes scapularis: identification of factor X and factor Xa as scaffolds for the inhibition of factor VIIa/tissue factor complex.
    Francischetti IM; Valenzuela JG; Andersen JF; Mather TN; Ribeiro JM
    Blood; 2002 May; 99(10):3602-12. PubMed ID: 11986214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticoagulant activity of a sulfated galactan: serpin-independent effect and specific interaction with factor Xa.
    Glauser BF; Rezende RM; Melo FR; Pereira MS; Francischetti IM; Monteiro RQ; Rezaie AR; Mourão PA
    Thromb Haemost; 2009 Dec; 102(6):1183-93. PubMed ID: 19967150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Draculin, the anticoagulant factor in vampire bat saliva, is a tight-binding, noncompetitive inhibitor of activated factor X.
    Fernandez AZ; Tablante A; Beguín S; Hemker HC; Apitz-Castro R
    Biochim Biophys Acta; 1999 Sep; 1434(1):135-42. PubMed ID: 10556567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factor Xa activation of factor V is of paramount importance in initiating the coagulation system: lessons from a tick salivary protein.
    Schuijt TJ; Bakhtiari K; Daffre S; Deponte K; Wielders SJ; Marquart JA; Hovius JW; van der Poll T; Fikrig E; Bunce MW; Camire RM; Nicolaes GA; Meijers JC; van 't Veer C
    Circulation; 2013 Jul; 128(3):254-66. PubMed ID: 23817575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of biological activity of draculin, the anticoagulant factor from vampire bat saliva, is strictly dependent on the appropriate glycosylation of the native molecule.
    Fernandez AZ; Tablante A; Bartoli F; Beguin S; Hemker HC; Apitz-Castro R
    Biochim Biophys Acta; 1998 Oct; 1425(2):291-9. PubMed ID: 9795244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A synthetic heparin mimetic that allosterically inhibits factor XIa and reduces thrombosis in vivo without enhanced risk of bleeding.
    Al-Horani RA; Abdelfadiel EI; Afosah DK; Morla S; Sistla JC; Mohammed B; Martin EJ; Sakagami M; Brophy DF; Desai UR
    J Thromb Haemost; 2019 Dec; 17(12):2110-2122. PubMed ID: 31397071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amblyomin-X having a Kunitz-type homologous domain, is a noncompetitive inhibitor of FXa and induces anticoagulation in vitro and in vivo.
    Branco VG; Iqbal A; Alvarez-Flores MP; Sciani JM; de Andrade SA; Iwai LK; Serrano SM; Chudzinski-Tavassi AM
    Biochim Biophys Acta; 2016 Oct; 1864(10):1428-35. PubMed ID: 27479486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dracula's children: molecular evolution of vampire bat venom.
    Low DH; Sunagar K; Undheim EA; Ali SA; Alagon AC; Ruder T; Jackson TN; Pineda Gonzalez S; King GF; Jones A; Antunes A; Fry BG
    J Proteomics; 2013 Aug; 89():95-111. PubMed ID: 23748026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NMR structure determination of Ixolaris and factor X(a) interaction reveals a noncanonical mechanism of Kunitz inhibition.
    De Paula VS; Sgourakis NG; Francischetti IMB; Almeida FCL; Monteiro RQ; Valente AP
    Blood; 2019 Aug; 134(8):699-708. PubMed ID: 31133602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Penthalaris, a novel recombinant five-Kunitz tissue factor pathway inhibitor (TFPI) from the salivary gland of the tick vector of Lyme disease, Ixodes scapularis.
    Francischetti IM; Mather TN; Ribeiro JM
    Thromb Haemost; 2004 May; 91(5):886-98. PubMed ID: 15116248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a novel selective factor Xa inhibitor, DJT06001, which reduces thrombus formation with low risk of bleeding.
    Hu X; Xiao Y; Yu C; Zuo Y; Yang W; Wang X; Gu B; Li J
    Eur J Pharmacol; 2018 Apr; 825():85-91. PubMed ID: 29475063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alboserpin, a factor Xa inhibitor from the mosquito vector of yellow fever, binds heparin and membrane phospholipids and exhibits antithrombotic activity.
    Calvo E; Mizurini DM; Sá-Nunes A; Ribeiro JM; Andersen JF; Mans BJ; Monteiro RQ; Kotsyfakis M; Francischetti IM
    J Biol Chem; 2011 Aug; 286(32):27998-8010. PubMed ID: 21673107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Schixator, a new FXa inhibitor from Schistosoma japonicum with antithrombotic effect and low bleeding risk.
    Ding L; Shu Z; Hao J; Luo X; Ye X; Zhu W; Duan W; Chen Z
    Biochem Biophys Res Commun; 2022 May; 603():138-143. PubMed ID: 35287055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fusion proteins comprising annexin V and Kunitz protease inhibitors are highly potent thrombogenic site-directed anticoagulants.
    Chen HH; Vicente CP; He L; Tollefsen DM; Wun TC
    Blood; 2005 May; 105(10):3902-9. PubMed ID: 15677561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The kunitz protease inhibitor domain of protease nexin-2 inhibits factor XIa and murine carotid artery and middle cerebral artery thrombosis.
    Wu W; Li H; Navaneetham D; Reichenbach ZW; Tuma RF; Walsh PN
    Blood; 2012 Jul; 120(3):671-7. PubMed ID: 22674803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The "Vampirome": Transcriptome and proteome analysis of the principal and accessory submaxillary glands of the vampire bat Desmodus rotundus, a vector of human rabies.
    Francischetti IM; Assumpção TC; Ma D; Li Y; Vicente EC; Uieda W; Ribeiro JM
    J Proteomics; 2013 Apr; 82():288-319. PubMed ID: 23411029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.